期刊文献+

5-氟尿嘧啶持续静滴48小时及分次静脉注射治疗胃癌疗效观察 被引量:5

下载PDF
导出
摘要 目的 比较 5 氟尿嘧啶 (5 Fu)持续静滴 4 8h与分次静脉注射治疗胃癌的疗效和不良反应。方法 将 5 3例胃癌随机分为A、B两组。A组应用醛氢叶酸 (LV) 30 0mg静滴 +5 Fu 0 5g静注后 ,再用 5 Fu 4 0 g持续静注 4 8h。在静注过程中 ,每 6小时 1次 ,口服LV 75mg ,共 7次 ;B组LV30 0mg静滴 1h后 ,用 5 Fu 0 75 g静注 ,连续 5d ,两组同时使用顺铂 (DDP) 80~10 0mg/m2 联合用药。全部病例均接受 3周期化疗。结果 A组中CR 5例 ,PR 16例 ,NC 7例 ,PD 4例 ,有效率 (CR +PR)为6 5 5 % ;B组中CR 2例 ,PR 6例 ,NC 6例 ,PD 7例 ,有效率 (CR +PR) 38 1%。两组有效率比较差异有显著性 (P <0 0 5 ) ;两组不良反应主要为骨髓抑制 ,口腔炎、腹泻、皮肤损害。A组分别为 15 6 %、18 8%、9 4 %、12 5 % ,B组分别为 4 2 9%、5 2 4 %、38 1%、4 7 6 %。两组差异有显著性 (P <0 0 5 )。结论  5 Fu持续静滴的疗效优于静脉推注 。
出处 《广西医学》 CAS 2005年第2期191-192,共2页 Guangxi Medical Journal
  • 相关文献

参考文献3

二级参考文献29

  • 1管忠震,何友兼,刘茂珍,周中梅.大剂量醛氢叶酸合并氟脲嘧啶(HDCF/5Fu)治疗晚期胃肠道癌的探讨[J].癌症,1989,8(6):421-424. 被引量:82
  • 2Carmichael J,Popiela T,Radstone D,et al.Randomized comparative study of ORZEL(R)(oral uracil/tegafur(UFTTM) plus leucovorin(LV))versus parenteral 5-fluorouracil(5-FU)plus LV in patients with metastatic colorectal cancer[J].Proc Am Soc Clin On col,1999,18:264a.
  • 3Van Cutsem E,Sorensen J,Cassidy J,et al.International phase Ⅲ study of oral eniluracil(EU)plus 5-fluorouracil(5-FU)versus intravenous(IV)5-FU plus leucovorin(LV)in the treatment of advanced colorectal cancer(ACC)[J].Proc Am Soc Clin Oncol,2001,20:131a.
  • 4Levin J,Schilsky R,Burris H,et al.North American phase Ⅲ study of oral eniluracil(EU)plus oral 5-fluorouracil(5-FU)versus intravenous(IV)5-FU plus lencovorin(LV)in the treatment of advanced colorectal cancer(ACC)[J].Proc Am Soc Clin Oncol,2001,20:132a.
  • 5Hoff PM,Ausari R,Batist G,et al.Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer:results of a randomized phase Ⅲ study[J].J Clin Oncol,2001,19(8):2282-2292.
  • 6Van Cutsem E,Twelves C,Cassidy J,et al.Oral capecitabine compared with intravenous fluorouracil plus teucovorin in patients with metastatic colorectal cancer:results of a large phase Ⅲ study[J].J Clin Oncol,2001,19(21):4097-4106.
  • 7Meta-Analysis Group in Cancer:Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal eancer[J].J Natl Cancer Inst,1996,88(5):252-258.
  • 8McArdle C,Kerr DJ,Ledermann J,et al.Intravenous(IV)vsintrahepatic arterial(IHA)5-FU/lencovorin for colorectal(CRC)liver metastasis:preliminary results of the mre ero5/eortc 40972 randomized trial[J].Eur J Cancer,2001,37(Suppl 6):257.
  • 9Knight RD,Miller LL,Pirotta N,et al.First-line irinotecan(C),fluorouracil(F),leucovorin(L)especially improves survival(OS) in metastatic colorectal cancer(MCRC)patients(PT)with favorable prognostic indicators[J].Proc Am Soc Clin Oncol,2000,19:255a.
  • 10Maasacesi C,Norman A,Price T,et al.A clinical nomogram for predicting long-term survival in advanced colorectal eancer[J].Eur J Cancer,2000,36(16):2044-2052.

共引文献159

同被引文献16

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部